Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Apr 01, 2026
Aemetis (AMTX): +128% Surge in 30 Days on RNG Growth and Earnings Momentum

Aemetis (AMTX): +128% Surge in 30 Days on RNG Growth and Earnings Momentum

Key Takeaways

  • AMTX stock surged +128% over the last 30 days, driven by strong dairy RNG (renewable natural gas) production growth and positive Q4 2025 earnings highlights despite revenue miss.
  • Over the past quarter, the stock rose approximately +100%, fueled by scaling biogas operations, ethanol plant upgrades, and India biodiesel contract wins.
  • Key catalysts include 61% YoY RNG production increase, projected $32M annual cash flow boost from plant efficiency upgrades, and supportive clean fuel policies.
  • Market sentiment shifted positively on renewable energy trends, though volatility remains high with beta over 2.0.
  • Analyst coverage updates and awards to CEO reinforced growth narrative in low-carbon fuels sector.

Understanding Aemetis (AMTX) and Its Place in Renewables

Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.

In the competitive renewable fuels industry, Aemetis holds a niche in circular bioeconomy solutions, leveraging facilities in California and India. Its exposure to government incentives like Low Carbon Fuel Standard (LCFS) credits and emerging federal 45Z clean fuel production tax credits (tax credits for low-emission fuels) underpins revenue. From what I see, the strong fundamentals in scaling RNG and plant upgrades explain the recent price strength, as these initiatives promise sustained cash flow amid rising demand for decarbonization in transportation.

AMTX Stock Performance: Breaking Down the Last 30 Days and Quarter

Over the last 30 days, AMTX stock delivered a robust +128% gain, rising from approximately $1.40 in early March 2026 to a close of $3.19 on March 31, 2026. The movement was volatile and trend-driven, with sharp rallies post-Q4 earnings on March 12, peaking near $3.60 before minor pullbacks, reflecting high trading volume exceeding 2 million shares on key days.

For the past quarter, the stock advanced around +100%, from roughly $1.59 in early January 2026 to the current level. Performance featured steady upward momentum interspersed with volatility, range-bound in low $1s early on before breaking out on operational news, aligning with broader renewable sector trends. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Key Drivers Behind the 30-Day Rally in AMTX

The 30-day surge was primarily propelled by Aemetis' Q4 and full-year 2025 earnings release on March 12, highlighting a 61% year-over-year increase in dairy RNG production and $12.2 million in net income from the biogas segment. Despite missing revenue estimates with $43.31 million versus expectations, the market focused on forward guidance: a mechanical vapor recompression (MVR) upgrade at the Keyes ethanol plant poised to add $32 million in annual cash flow upon 2026 completion.

India biodiesel deliveries resumed under a $24 million allocation from oil marketing companies, boosting sentiment. Analyst updates, like Stonegate Capital's coverage, and CEO Eric McAfee's lifetime achievement award in the bioeconomy amplified positive market sentiment. Sector tailwinds from clean fuel policies, including California's year-round E15 ethanol approval, further supported the rally amid heightened trading volume and short interest reduction. One thing that stands out is how these operational wins have shifted investor focus.

What Fueled AMTX's Quarterly Gains

The quarterly uptrend stemmed from sustained operational progress in RNG and biofuels. Dairy biogas digesters scaled, turning profitable and generating strong EBITDA potential, countering ethanol segment cyclicality. Broader macroeconomic support for renewables—rising LCFS credit values, federal incentives via the "One Big Beautiful Bill," and demand for low-carbon trucking/aviation fuels—provided tailwinds.

India operations gained traction with biodiesel contracts, diversifying revenue. Institutional behavior shifted positively post-earnings, with high short interest unwind contributing to momentum. Competitive positioning strengthened via carbon intensity reductions, though debt levels and liquidity risks tempered gains. Cumulative impact favored growth narratives over near-term losses ($77 million full-year net loss). In my view, this balance of progress and challenges is worth monitoring closely.

Trending AI Robots

I’ve found Tickeron’s Trending AI Robots particularly useful in my analysis of stocks like AMTX. This page showcases the platform's top-performing AI trading bots from hundreds available, which analyze and trade thousands of tickers across various strategies, timeframes, and performance metrics like win rate, profit factor, and drawdown. These curated bots represent the most relevant and successful ones based on recent market conditions, offering insights into automated trading patterns. Whether momentum-based, mean-reversion, or sector-specific, they provide transparent backtested and live results that help refine my own trading decisions.

Looking Ahead: What to Watch for AMTX Investors

Investors should monitor upcoming Q1 2026 earnings for RNG production updates and MVR upgrade progress. Industry trends in sustainable aviation fuel (SAF) demand and biogas expansion could influence sentiment. Macro factors like federal 45Z credit implementation, LCFS credit prices, and interest rates impacting capex remain key.

Strategic developments, including dairy digester network growth and India biodiesel scaling, alongside risks from commodity price volatility (corn, dairy waste) and $300 million debt load, warrant attention. Potential catalysts include new partnerships or policy expansions; watch regulatory changes in renewable mandates. I’m watching these elements closely as they could shape the next moves.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: AMTX

AMTX's Stochastic Oscillator is remaining in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +4.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMTX advanced for three days, in 199 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 91 of 119 cases where AMTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMTX as a result. In 74 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for AMTX turned negative on September 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 31 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.

AMTX moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

AMTX broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. AMTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-3.220) is normal, around the industry mean (6.363). P/E Ratio (13.770) is within average values for comparable stocks, (209.940). AMTX's Projected Growth (PEG Ratio) (19.780) is very high in comparison to the industry average of (1.548). Dividend Yield (0.000) settles around the average of (0.013) among similar stocks. P/S Ratio (0.555) is also within normal values, averaging (48.960).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.08B. The market cap for tickers in the group ranges from 50 to 217.6B. LIN holds the highest valuation in this group at 217.6B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was 1%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 2%. FEAM experienced the highest price growth at 39%, while CITR experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 7%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 55
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 83
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
AMTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of renewable chemicals and fuels using patented microbes and processes

Industry ChemicalsSpecialty

Industry
Chemicals Specialty
Address
20400 Stevens Creek Boulevard
Phone
+1 408 213-0940
Employees
220
Web
https://www.aemetis.com
Interact to see
Advertisement
United Therapeutics Corporation focuses on biotechnology innovations for chronic and life-threatening conditions, particularly in pulmonary diseases. The company's portfolio centers on treatments for pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF), featuring products like Tyvaso (treprostinil inhalation solution), Orenitram (oral treprostinil), Remodulin, and Adcirca.
SE stock declined -21% over the past 30 days, primarily triggered by a Q4 2025 earnings EPS miss despite revenue beat, leading to a sharp 16% single-day drop. Over the past quarter, the stock fell -37%, reflecting sustained pressure from analyst price target cuts and concerns over rising growth investments.
TaskUs, Inc. (TASK) stands out as a leading provider of outsourced digital services and next-generation customer experience solutions. The company focuses on digital customer experience (Digital CX), trust and safety (monitoring user-generated content for compliance), and artificial intelligence (AI) services such as data labeling and annotation for machine learning models. From its headquarters in New Braunfels, Texas, TaskUs serves high-growth sectors like social media, e-commerce, gaming, streaming, food delivery, ride-sharing, technology, financial services, and healthcare.
WVE stock plunged approximately -52% over the past 30 days, driven primarily by disappointing high-dose data from the Phase 1 INLIGHT trial of obesity candidate WVE-007 on March 26, which erased prior gains from positive initial results. Over the past quarter, shares declined around -61%, reflecting high volatility in biotech sentiment amid clinical trial outcomes and broader sector pressures on clinical-stage firms
KOD stock surged +39% over the past 30 days, driven primarily by positive Phase 3 GLOW2 trial results for Zenkuda in diabetic retinopathy. Over the past quarter, shares gained +36%, reflecting anticipation of clinical catalysts and a successful $184 million capital raise.
Lam Research Corporation stands out as a leading supplier of semiconductor processing equipment essential for fabricating integrated circuits. The company designs, manufactures, markets, refurbishes, and services tools for deposition, etch, and clean processes, serving major chipmakers across the United States, China, Korea, Taiwan, Japan, and Europe. At its core, Lam's business revolves around innovative systems like ALTUS for film deposition and SABRE for electrochemical deposition, which are vital for advanced nodes in AI, memory, and logic chips.
Roblox Corporation (RBLX) runs a platform where millions of users create and dive into immersive 3D experiences. The business centers on a virtual economy: users buy Robux for in-game items, and creators cash out through the developer exchange (DevEx) program. In the online gaming space, Roblox stands out as a metaverse pioneer, going up against the likes of Epic Games' Fortnite and newer AI-driven platforms. The fundamentals reflect impressive user growth—daily active users (DAUs) reached 144 million in Q4 2025, a 69% jump year-over-year—but ongoing net losses underscore the heavy spending on infrastructure, AI, and safety. From what I see, this tension between growth and profitability has fueled much of the recent volatility in RBLX shares, as investors weigh strong engagement against shrinking margins.
Megan Holdings Limited (MGN) is a Malaysia-based company focused on the development, construction, maintenance, and upgrade of aquaculture and agriculture farms, along with related services. At its core, the business provides end-to-end solutions for shrimp farms, from design and building hatcheries to ongoing maintenance. It operates mainly in Sabah, Malaysia, across segments like aquaculture/agriculture, industrial solutions such as smart technologies, and investments in marketable securities.
Megan Holdings Limited (MGN), based in Kuala Lumpur and founded in 2020, focuses on developing, constructing, maintaining, and upgrading aquaculture and agriculture farms in Malaysia. The company operates in three segments—aquaculture and agriculture, industrial solutions like supplying smart technologies and machinery rentals, and investments in marketable securities—carving out a niche in engineering and construction within the Industrials sector. Its subsidiary status under Star Sprite Limited adds a layer of operational stability.
Pony AI Inc. (PONY) stands out as a leading player in autonomous mobility, dedicated to bringing self-driving technology to commercial use. Founded in 2016 and based in Guangzhou, China, the company operates across China, the U.S., and other international markets, offering robotaxi services, robotruck logistics, and licensing for intelligent driving solutions. Its business model leans heavily on asset-light partnerships with original equipment manufacturers (OEMs), transportation network companies (TNCs), and logistics platforms.
Maze Therapeutics, Inc. (MAZE) is a clinical-stage biopharmaceutical company focused on developing small-molecule precision medicines for kidney and metabolic diseases. In my view, the company's core strength lies in its proprietary Maze Compass platform, which uses human genetics and variant functionalization to identify and advance therapies targeting genetically defined patient populations.
In my view, JPM stands out as the largest U.S. bank by assets and market capitalization, commanding leading market shares across key segments. It holds approximately 11.1% of U.S. retail deposits, 23.6% of credit card sales volume, 8.4% of global investment banking fees, 11.8% of markets revenue, and 10% of treasury services revenue. This diversified "universal banking model" spans consumer and community banking, commercial and investment banking, and asset and wealth management, generating resilient revenue streams.
In recent sessions, WMT has held steady around $124, pulling back from February highs near $134. From what I see, this resilience stands out as the stock has outperformed broader indices year-to-date, thanks to its defensive role in groceries and essentials. Shoppers are leaning toward value options, and consistent volumes show ongoing institutional support. The premium valuation reflects confidence in Walmart's omnichannel progress and market share gains. Even with macro headwinds, I view WMT as a portfolio staple during uncertain times.
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
NKE shares are tumbling approximately 11% in premarket trading on April 1, 2026, sliding to near nine-year lows after the previous close of $52.82. The primary catalyst is Nike's weak Q4 fiscal 2026 guidance: management projected a 2%–4% revenue decline, sharply missing analyst expectations of approximately 1.9% growth.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.